|
Volumn 44, Issue 16, 2001, Pages 2675-2678
|
(-)3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: A dual PPAR agonist with potent antihyperglycemic and lipid modulating activity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 [4 [2 (PHENOXAZIN 10 YL)ETHOXY]PHENYL] 2 ETHOXYPROPANOIC ACID;
ANTIDIABETIC AGENT;
ANTILIPEMIC AGENT;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;
PHENOXAZINE DERIVATIVE;
RAGAGLITAZAR;
ROSIGLITAZONE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
DIABETES MELLITUS;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DYSLIPIDEMIA;
GLUCOSE BLOOD LEVEL;
MALE;
NONHUMAN;
RAT;
ANIMALS;
BIOLOGICAL AVAILABILITY;
BLOOD GLUCOSE;
DIABETES COMPLICATIONS;
DIABETES MELLITUS;
HYPERLIPIDEMIAS;
HYPOGLYCEMIC AGENTS;
INSULIN RESISTANCE;
MICE;
OXAZINES;
PHENYLPROPIONATES;
RATS;
RATS, WISTAR;
RECEPTORS, CYTOPLASMIC AND NUCLEAR;
STEREOISOMERISM;
TRANSCRIPTION FACTORS;
TRIGLYCERIDES;
|
EID: 0035797363
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm010143b Document Type: Article |
Times cited : (152)
|
References (11)
|